My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Clearside Biomedical, Inc. - Common Stock (NQ:CLSD)

0.5613 -0.0387 (-6.45%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearside Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 27, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.

Via Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Clearside Biomedical Q2 Earnings ↗

August 09, 2022

Clearside Biomedical (NASDAQ:CLSD) reported its Q2 earnings results on Tuesday, August 9, 2022. Here's what investors need to know about the announcement. Earnings Clearside Biomedical reported...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 08, 2022

Via Benzinga

Clearside Biomedical: Q1 Earnings Insights ↗

May 11, 2022

Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary ↗

July 26, 2022

Via Benzinga

Clearside Biomedical Sees Initial-Stage Chronic Eye Disorder Study Results In Q4 2022 ↗

July 26, 2022

Clearside Biomedical (NASDAQ: CLSD) has completed dosing in Cohorts 3 and 4 of OASIS study of its lead drug CLS-AX (axitinib injectable suspension) in patients with neovascular age-related macular...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 06, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 27, 2022

It's time to dive into the world of early morning trading yet again with the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

20 Stocks Moving in Wednesday's Pre-Market Session ↗

April 27, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net...

Via Benzinga

30 Stocks Moving in Tuesday's Pre-Market Session ↗

March 22, 2022

Gainers Smart for Life, Inc. (NASDAQ: SMFL) rose 75.3% to $1.63 in pre-market trading. Smart For Life recently said it is launching various products under the Doctors Scientific...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 14, 2022

Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 18.7% to $1.65 during Monday's pre-market session. The market value of their outstanding shares is at $51.1 million....

Via Benzinga

95 Biggest Movers From Friday ↗

March 14, 2022

Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9....

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Orphazyme Shares Plunge ↗

March 11, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday. The Dow traded up 0.07% to 33,198.82 while the NASDAQ fell 1.18% to 12,...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 11, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) shares increased by 35.2% to $1.82 during Friday's regular session. Clearside Biomedical's stock is trading at a volume...

Via Benzinga

Mid-Day Market Update: Gold Down 1%; Clearside Biomedical Shares Jump ↗

March 11, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq dropping around 100 points on Friday. The Dow traded up 0.49% to 33,336.14 while the NASDAQ fell 0.73% to 13,032....

Via Benzinga

Why Clearside Biomedical Shares Are Surging Today ↗

March 11, 2022

Clearside Biomedical Inc (NASDAQ: CLSD) shares are trading higher Friday after the company reported better-than-expected fourth-quarter financial results. Clearside reported...

Via Benzinga

50 Stocks Moving In Friday's Mid-Day Session ↗

March 11, 2022

Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) shares rose 63.5% to $1.13....

Via Benzinga

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China ↗

March 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 11, 2022

Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!

Via InvestorPlace

30 Stocks Moving in Friday's Pre-Market Session ↗

March 11, 2022

Gainers Excellon Resources Inc. (NYSE: EXN) rose 133.7% to $2.29 in pre-market trading after jumping around 13% on Thursday. Marygold Companies (NYSE: MGLD) rose 107.4% to...

Via Benzinga

Benzinga's After-Hours Movers & News: DocuSign, Clearside Biomedical And More ↗

March 10, 2022

Benzinga's “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...

Via Benzinga

Recap: Clearside Biomedical Q4 Earnings ↗

March 10, 2022

Clearside Biomedical (NASDAQ:CLSD) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement....

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 10, 2022

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.8% to $1.55 during Thursday's after-market session. The company's market cap stands at $92.4 million. As per the press release, Q4...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 25, 2022

Gainers Kaleido Biosciences (NASDAQ:KLDO) stock rose 14.6% to $1.73 during Friday's pre-market session. The market value of their outstanding shares is at $73.6...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 24, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.